Skip to content

Clinical trials

Terminated Lung Diseases, Interstitial trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Terminated Country / region: United Kingdom Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20121
20161
20171
20181
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
EMD Serono Research & Development Institute, Inc.1
Gilead Sciences1
Kyntra Bio1
Maximilian Nussbaumer1
Novartis Pharmaceuticals1
PureTech1
Theravance Biopharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial9
Idiopathic Pulmonary Fibrosis5
Pulmonary Fibrosis5
Fibrosis3
Idiopathic Interstitial Pneumonias2
Scleroderma, Systemic2
Asthma1
Bronchomalacia1
COVID-191
Lung Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.